Novavax has applied for EU approval of the corona vaccine – first details.
Brussels – The vaccine manufacturer Novavax has applied for EU approval for its corona vaccine *. Most recently, the US company had already submitted all relevant data to the World Health Organization (WHO). The Amsterdam-based EU Medicines Agency (EMA) announced on Wednesday that it had already started testing and that it is expected to announce a decision in "a few weeks".
Corona: Novavax vaccine is to be approved in the EU
The Novavax vaccine is a “traditional” vaccine. * The vaccine is based on proteins, in contrast to the previous corona vaccines, which were developed on the basis of genes.
More soon. (tu / AFP) * fr.de is an offer from IPPEN.MEDIA.
